Zoetis Stock (NYSE: ZTS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 26.000 / 3.723M |
Day Range | - - - |
52 Wk Range | 144.800 - 201.920 |
Market Cap | $77.132B |
P/E Ratio | 32.570 |
Dividend Yield | 1.020% |
Exchange | NYSE |
RSI | 59 |
Short Interest | 0.7% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Zoetis (NYSE: ZTS) through any online brokerage.
Other companies in Zoetis’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Zoetis (NYSE: ZTS) was reported by HSBC on Wednesday, May 8, 2024. The analyst firm set a price target for 225.00 expecting ZTS to rise to within 12 months (a possible 33.10% upside). 19 analyst firms have reported ratings in the last year.
The stock price for Zoetis (NYSE: ZTS) is $169.04 last updated May 10, 2024 at 4:00 PM EDT.
A quarterly cash dividend of $0.43 per share of Class A Common Stock. The quarterly cash dividend was payable on June 4, 2024 to stockholders of record on April 18, 2024.
Zoetis’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Zoetis.
Zoetis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.